Skip to main content

Table 1 Antibiotic susceptibility results of the tested isolates

From: Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia

Antibiotic Total susceptibility No. (%) (512) Inpatient isolates No. (%) (397) Outpatient isolates No. (%) (115)
Vancomycin 512(100) 397(100) 115(100)
Quinupristin/dalfopristin 512(100) 397(100) 115(100)
Linezolid 491(95.9) 386(97.2) 105(91.3)
Chloramphenicol 413(80.7) 302(76.1) 111(96.5)
Gatifloxacin 404(78.9) 299(75.3) 105(91.3)
Mupirocin 394(77.0) 292(73.6) 102(88.7)
Gentamicin 203(39.6) 118(29.7) 85(73.9)
Sulfamethoxazole/trimethoprim 173(33.8) 85(21.4) 88(76.5)
Fusidic acid 22(4.3) 15(3.8) 7(6.1)